• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CSL01005 重组人血管内皮抑制素(UH-16) Other Biological Products(1) New Drug Application 2001-01-22 烟台荣昌生物工程有限公司 RemeGen Co Ltd Certificate Issued 2001-07-24 view
CSL20020053 重组人血管内皮抑制素 Recombinant Human Endostatin Injection Biological Products(1) New Drug Application 2002-07-15 广东肇庆星湖生物科技股份有限公司 Star Lake Bioscience Co inc Zhaoqing Guangdong Certificate Issued 2003-05-16 view
X0405545 重组人血管内皮抑制素 Recombinant Human Endostatin Injection Biological Products New Drug Application 2004-09-30 烟台麦得津生物工程股份有限公司 Shandong Simcere Bio-Pharmaceutical Co Ltd Certificate Issued 2005-09-22 view
CXSB0600041 重组人血管内皮抑素注射液 Recombinant Human Endostatin Injection Biological Products Supplementary Application 2006-06-16 江苏吴中实业股份有限公司 JiangSu WuZhong Pharmaceutical Development Co Ltd Certificate Issued 2007-05-17 view
CXSB0600125 重组人血管内皮抑制素注射液 Recombinant Human Endostatin Injection Biological Products Supplementary Application 2006-12-14 山东先声麦得津生物制药有限公司 Shandong Simcere Bio-Pharmaceutical Co Ltd Certificate Issued 2007-09-18 view
CXSB0700080 重组人血管内皮抑制素注射液 Recombinant Human Endostatin Injection Biological Products Supplementary Application 2007-08-27 山东先声麦得津生物制药有限公司 Shandong Simcere Bio-Pharmaceutical Co Ltd Certificate Issued 2008-09-19 view
CXSL0800037 聚乙二醇重组人血管内皮抑制素注射液 Injection Biological Products(1) New Drug Application 2008-10-07 清华大学 Tsinghua University Certificate Issued 2009-03-19 view
CXSB1000006 聚乙二醇重组人血管内皮抑制素注射液 Injection Biological Products Supplementary Application 2010-03-30 清华大学 Tsinghua University Certificate Issued 2010-07-13 view
CXSB1000001 重组人血管内皮抑制素注射液 Recombinant Human Endostatin Injection Biological Products Supplementary Application 2010-04-12 山东先声麦得津生物制药有限公司 Shandong Simcere Bio-Pharmaceutical Co Ltd In Review 2012-07-02 view
CXSB1000018 重组人血管内皮抑素注射液 Recombinant Human Endostatin Injection Biological Products Supplementary Application 2010-05-25 江苏吴中医药集团有限公司苏州中凯生物制药厂 Jiangsu Wuzhong Pharmaceutical Group Co Ltd Suzhou Zhongkai Biopharmaceutical Factory Certificate Issued 2011-02-15 view
CYSB1100375 重组人血管内皮抑制素注射液 Recombinant Human Endostatin Injection Biological Products Supplementary Application 2011-07-27 山东先声麦得津生物制药有限公司 Shandong Simcere Bio-Pharmaceutical Co Ltd Certificate Issued 2013-05-31 view
CXSL1100045 注射用聚乙二醇化重组人血管内皮抑制素 Lyophilized Biological Products(9) New Drug Application 2011-12-01 山东先声麦得津生物制药有限公司 Shandong Simcere Bio-Pharmaceutical Co Ltd Certificate Issued 2014-07-31 view
CXSS1800005 重组人血管内皮抑素注射液 Recombinant Human Endostatin Injection Biological Products(1) New Drug Application 2018-03-09 江苏吴中医药集团有限公司苏州中凯生物制药厂 Jiangsu Wuzhong Pharmaceutical Group Co Ltd Suzhou Zhongkai Biopharmaceutical Factory Certificate Issued 2019-07-17 view
CYSB2000017 重组人血管内皮抑制素注射液 Recombinant Human Endostatin Injection Biological Products Supplementary Application 2020-01-23 山东先声生物制药有限公司 Shandong Simcere Bio-Pharmaceutical Co Ltd In Review 2020-01-22 view
CXSL2100008 重组人血管内皮抑制素注射液 Recombinant Human Endostatin Injection Biological Products(2.2) New Drug Application 2021-01-09 山东先声生物制药有限公司 Shandong Simcere Bio-Pharmaceutical Co Ltd In Review 2021-01-08 view